Glycosphingolipids mediate pneumocystis cell wall β-glucan activation of the IL-23/IL-17 axis in human dendritic

Eva M Carmona1, Theodore J Kottom, Deanne M Hebrink

  • 1Thoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Insights

Pneumocystis fungal cell walls stimulate human immune cells, activating the IL-23/IL-17 pathway crucial for fighting fungal infections. This involves dectin-1 receptor and glycosphingolipid-rich membrane domains.

Area of Science:

  • Immunology
  • Mycology
  • Cell Biology

Background:

  • Pneumocystis species are opportunistic fungi causing severe pneumonia in immunocompromised individuals.
  • Interleukin-17 (IL-17) responses are critical for host defense against fungal pathogens.

Purpose of the Study:

  • To investigate how Pneumocystis cell-surface β-glucans (PCBG) activate human immune cells.
  • To elucidate the signaling pathways involved in PCBG-induced immune responses.

Main Methods:

  • Stimulation of human dendritic cells (DCs) with PCBG.
  • Measurement of cytokine secretion (IL-23, IL-6, IL-17, IL-22).
  • Analysis of DC activation pathways involving dectin-1, Syk kinase, NF-κB, and glycosphingolipid microdomains.

Main Results:

  • PCBG stimulates human DCs to secrete IL-23 and IL-6, promoting a T helper-17 (Th17) phenotype.
  • PCBG-stimulated DCs induce lymphocytes to secrete IL-17 and IL-22.
  • DC activation involves dectin-1, Syk kinase, NF-κB translocation, and glycosphingolipid microdomains with lactosylceramide accumulation.

Conclusions:

  • Pneumocystis β-glucans activate the IL-23/IL-17 axis via a mechanism initiated by glycosphingolipids.
  • This pathway is essential for host defense against Pneumocystis infections.